Clinical Trials Browser

Phase 2 × Urinary Bladder Neoplasms × Therapeutics × Clear all

NCT07307456 2025-12-29

Tremelimumab Combined With BCG Perfusion for the Treatment of HR-NMIBC After TURBT Surgery Exploration

Phase 2 Recruiting

Urinary Bladder Neoplasms